Stocktoria

ACHIEVE LIFE SCIENCES, INC. ACHV

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-12 · LEI

ACHIEVE LIFE SCIENCES, INC. statistics & valuation

Market cap$618.0M
P / B28.7×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-202.30% -67.00% -80.30% -90.80% -39.50% -118.20% -510.10% -190.60% -254.00% 2016201720182019202020212022202320242025
Shares outstanding
21230 1.2M 6.7M 1.5M 6.1M 9.5M 17.9M 21.2M 34.7M 53.2M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-32.40% -107.00% -66.50% -77.80% -36.60% -69.80% -141.30% -153.90% -103.10% -130.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$5.42 -$4.08 -$4.00 -$1.50 -$1.24 -$1.25 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-130.8%-103.1%-153.9%-141.3%-69.8%-36.6%-77.8%-66.5%-107.0%-32.4%
Return on equity-254.0%-190.6%2059.0%-510.1%-118.2%-39.5%-90.8%-80.3%-67.0%-202.3%
Current ratio4.395.460.821.279.8012.606.044.752.930.01

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.